Texas Halo Fund

Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.

Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.

Galen Data, Inc., founded in 2016 and based in Houston, Texas, offers a cloud-based software platform designed for the healthcare sector, specifically targeting medical device connectivity and data management. This turn-key solution allows medical device companies to centralize their data, ensuring secure storage and facilitating data visualization and analysis. The platform is designed to meet the needs of a wide range of clients, from startups to large medical technology and pharmaceutical companies, enabling them to focus on their core innovations without the burden of software design and data management complexities. Galen Data's system is compliant with FDA and CE Mark regulations, as well as HIPAA and GDPR requirements, and holds ISO 13485:2016 certification. By integrating with major electronic health record systems, the platform enhances patient compliance tracking and reduces regulatory risks, ultimately supporting healthcare providers in optimizing information usage for improved clinical outcomes.

Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.

Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Galen Data, Inc., founded in 2016 and based in Houston, Texas, offers a cloud-based software platform designed for the healthcare sector, specifically targeting medical device connectivity and data management. This turn-key solution allows medical device companies to centralize their data, ensuring secure storage and facilitating data visualization and analysis. The platform is designed to meet the needs of a wide range of clients, from startups to large medical technology and pharmaceutical companies, enabling them to focus on their core innovations without the burden of software design and data management complexities. Galen Data's system is compliant with FDA and CE Mark regulations, as well as HIPAA and GDPR requirements, and holds ISO 13485:2016 certification. By integrating with major electronic health record systems, the platform enhances patient compliance tracking and reduces regulatory risks, ultimately supporting healthcare providers in optimizing information usage for improved clinical outcomes.

Zibrio is a balance diagnostics company based in Houston, Texas, founded in 2017. The company has developed a unique biometrics device that utilizes advanced knowledge of postural control and machine learning to detect subtle changes in balance. Originally based on technology developed for NASA to assess astronauts' stability post-spaceflight, Zibrio's technology aims to empower users to monitor and improve their health. The device provides insights into individual balance profiles, offering assistance and advice to enhance stability, reduce the risk of falls, and promote overall well-being. Through its innovative approach, Zibrio seeks to advance the understanding of balance and contribute to better health outcomes for its users.

Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.

MacroFab is a marketplace for electronics manufacturing from prototype to high scale production. Their platform is re-shaping the $480B contract manufacturing market by transforming the experience from a manual, time-intensive, and error-prone process performed by large teams of people, into a real-time, streamlined, and connected software-driven experience while providing access to unlimited factory capacity in North America. The platform also uploads a PCB board design, gets an instant quote and the board is printed in the company's factory, enabling startups, manufacturers, and enterprises to design, customize and automate the PCB manufacturing process and save time, effort and money. Macrofab was founded in 2013 and is headquartered in Houston, Texas, United States.

Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.

DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.

Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network. The company was founded in 2011 and is based in Houston, Texas.

Onit, Inc. specializes in developing legal project management and workflow automation software designed to enhance productivity and streamline operations across various business departments. The company's offerings include Enterprise Legal Management, Matter Management, Legal Spend Management, Contract Lifecycle Management, and Legal Holds, which collectively facilitate the efficient handling of legal matters and spending. Additionally, Onit provides a self-service portal for Legal Service Requests and tools like Apptitude for workflow automation and Precedent, an artificial intelligence platform. By allowing users to create custom applications without reliance on IT support, Onit simplifies business processes that are typically manual and cumbersome. Founded in 2011 and headquartered in Houston, Texas, with additional offices in Austin, Auckland, and Pune, Onit serves a diverse range of industries, including technology, insurance, healthcare, and finance, helping clients to automate processes, reduce costs, and maximize productivity.

DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.